Abstract:Key PointsRecently, arrays of clustered, regularly interspaced short palindromic repeats (CRISPRs) have been implicated in a novel genetic interference pathway that limits phage infection and plasmid conjugation. CRISPR loci keep a record of past infections to provide bacteria and archaea with a 'genetic memory' that directs the rejection of invader DNA molecules; therefore these loci constitute an adaptive immune system.CRISPRs (which are approximately 25–50 nucleotides long) are separated by similarly short sequences called spacers that match bacteriophage or plasmid sequences and specify the targets of interference. CRISPR-associated (cas) genes, a set of conserved genes that are associated with these loci, are usually present on one or the other side of the array.CRISPR loci are transcribed as a long precursor that is processed by Cas proteins within the repeat sequences to generate small CRISPR RNAs (crRNAs). The crRNAs serve as guides for target recognition during CRISPR interference. crRNA–Cas ribonucleoprotein complexes seem to generally target invading DNA sequences during interference but may also target RNAs in some species.Upon bacteriophage challenge of a CRISPR-containing bacterial population, mutants resistant to the infection arise through the incorporation of additional spacer sequences derived from the challenging phage. This allows the bacteria to evolve rapidly and adapt to the viruses in the environment.Bacteriophages and plasmids can mobilize foreign genetic material between cells, a process known as horizontal gene transfer (HGT), which is a fundamental source of genetic variability for the evolution of bacteria and archaea. CRISPR interference prevents phage infection and plasmid conjugation and therefore constitutes a natural barrier to HGT. In addition, bacteriophages constantly mutate to evade CRISPR defence. Therefore, CRISPR interference has an important role in the evolution of microbial communities.

Primed acquisition and microhomology-mediated end-joining cooperate to confer specific CRISPR immunity against invasive genetic elements

Molecular mechanisms of CRISPR–Cas spacer acquisition

CRISPR-mediated Host Genomic DNA Damage is Efficiently Repaired Through Microhomology-Mediated End Joining in Zymomonas Mobilis.

Cas4 Nucleases Can Effect Specific Integration of CRISPR Spacers

Host nucleases generate prespacers for primed adaptation in the E. coli type I-E CRISPR-Cas system

Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria

Crosstalk between three CRISPR-Cas types enables primed type VI-A adaptation in Listeria seeligeri

Unique properties of spacer acquisition by the type III-A CRISPR-Cas system

Cas1 mediates the interference stage in a phage-encoded CRISPR–Cas system

Prespacers formed during primed adaptation associate with the Cas1–Cas2 adaptation complex and the Cas3 interference nuclease–helicase

An Active Type I-E CRISPR-Cas System Identified in Streptomyces avermitilis

CRISPR-Cas immunity in prokaryotes

Processing and integration of functionally oriented prespacers in the Escherichia coli CRISPR system depends on bacterial host exonucleases

Deep mutational scanning identifies variants of Cas1 and Cas2 that increase spacer acquisition in type II-A CRISPR-Cas systems

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system

Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system

CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea

The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity

CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures

Self‐targeting spacers in CRISPR‐array: Accidental occurrence or evolutionarily conserved phenomenon